MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$129,972K
Accounts receivable, net
$78,129K
Prepaid expenses and
other current assets
$15,353K
Inventory
$5,518K
Total property and
equipment, gross
$4,539K
Total current assets
$228,972K
Inventory, non-current
$20,732K
Other long-term
assets
$2,917K
Restricted cash
$2,861K
Operating lease
right-of-use assets
$2,603K
Property and equipment,
net
$1,064K
Less accumulated
depreciation and...
$3,475K
Total assets
$259,149K
Accumulated deficit
-$1,484,258K
Total liabilities and
stockholders' deficit
$259,149K
Total stockholders'
deficit
-$438,169K
Additional paid-in capital
$1,046,083K
Common stock, 0.0001
par value...
$6K
Total liabilities
$697,318K
Revenue interest
financing liability
$350,122K
Long-term debt, net of
discount
$209,087K
Total current
liabilities
$132,044K
Other long-term
liabilities
$4,000K
Operating lease
liabilities
$2,065K
Accrued expenses
$89,831K
Current portion of
revenue interest...
$27,249K
Other current
liabilities
$7,500K
Accounts payable
$4,983K
Accrued interest
$1,833K
Operating lease
liabilities, current
$648K
Back
Back
Balance Sheet
source: myfinsight.com
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT)